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Journal of Interdisciplinary Nanomedicine ISSN 2058-3273AbstractPreparation and characterisation of a ternary lipid-peptide-siRNA
nanoparticle delivery system
Shahd Abuhelal*
King’s College London/Institute of Pharmaceutical Science
siRNA treatment can result in decreased protein expression and could be used to treat cancer or other diseases.
Successful application depends on efﬁcient delivery inside target cells. Here, we aim to design and optimise a
nano-carrier suitable for siRNA delivery, with high encapsulation efﬁciency and stability for use in vitro and
in vivo to target cancer.
Liposomes and pH-sensitive peptides assembled as ternary complex were investigated as siRNA delivery systems.
Physicochemical characteristics (size, zeta potential, siRNA maintenance, release and aggregation) were tested.
Cell uptake and luciferase knock down were evaluated in vitro, and some complexes tested for biodistribution
in vivo.
Hydrodynamic size and zeta potential of the lipoplex, peptide complexes and ternary complexs were similar. Al-
though lipoplexes showed better encapsulation, they were less stable in serum. Ternary complexes offered better
protection for the siRNA. Improved cell uptake was seen for ternary complexes in comparison with peptide complex
and lipoplex. Knock down studies revealed optimal effects ternary complexes, and preliminary in vivo experiments
showed tumour accumulation of lipoplex.
These siRNA delivery vehicles appear promising for in vivo applications, and work is now focused on the improve-
ment of cell targeting, in vitro and in vivo PK/PD.© 2016 The Authors.
Journal of Interdisciplinary Nanomedicine © 2016 British Society for Nanomedicine and John and Wiley & Sons Ltd
2016 | Volume 1 | Issue 2 |
Page 35
AbstractMagnetic nanoparticle engineering of canine olfactory mucosal cells:
implications for canine spinal injury
Chris Adams*
Keele University
Magnetic nanoparticles (MNPs) are key translational platforms with the ability to label cells for non-invasive imag-
ing and genetically engineer cells for release of therapeutic biomolecules. We show for the ﬁrst time that applica-
tion of magnetic ﬁelds can safely enhance MNP mediated labelling and genetic engineering of autologous canine
olfactory mucosal cells (cOMCs), a key veterinary cell population for treatment of spinal injury in companion dogs.
Crucially, the developed protocols were successfully combined with advanced minicircle DNA vectors to deliver
brain derived neurotrophic factor (important in promoting nerve ﬁbre outgrowth) to cOMCs. Minicircles have dis-
tinct advantages for clinical gene delivery due to their small size, lack of bacterial backbone and duration of trans-
gene expression. Finally, we also show that MNP labelling can facilitate imaging of cOMCs encapsulated in
implantable collagen hydrogels using non-invasive magnetic resonance imaging. A combination of these methodol-
ogies could enable translation of safe and effective cOMC transplantation strategies.2016 | Volume 1 | Issue 2 |
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AbstractPolymer nanomedicine: Understanding activity at the cellular and
molecular level using advanced metabolomics
Mohammad Ahmad Abdallah Al-Natour*
University and Institution: University of Nottingham
Abstract
Recent years have witnessed unexpected growth of research on the medical applications of nanotechnology
(nanomedicine), especially the use of nanoparticles (NPs) in the diagnosis and treatment of disease. Among these
polymeric NPs have many advantages; they can be prepared from biocompatible FDA approved polymers, easily
functionalized with smart ligands, and tailored to control the release of encapsulated drugs. However the impact
of these NPs at the molecular and cellular levels has not been fully studied.
We have applied cell based metabolomics methodology to investigate the cellular metabolic changes in human-
like macrophages after exposure to ﬁve different poly(lactic-co-glycolic acid (PLGA) NPs. The study revealed that
all NPs induced oxidative stress and shift in energy metabolism from citric acid cycle to glycolysis. However none
of them were toxic. Metabolites fold changes showed that PEG-PLGA NPs had the minor impact on the cellular
metabolism.2016 | Volume 1 | Issue 2 |
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AbstractThe co-administration of anticancer and pro-apoptotic agents as novel
approach in liver cancer therapy
Wejdan Al-Shakarchi*
Institute for Science and Technology in Medicine, Keele University
Abstract
Hepatocellular carcinoma accounts for 85% of liver cancers that originate in liver cells. This type of tumour is
characterised by defective or ineffective apoptosis, which is considered to be the main cause of cancer progression.
Cytochrome-C (heme protein) triggers mitochondrial apoptosis and is responsible for activation of the downstream
caspase apoptosis pathway during cell death in tumour cells. However, there is a signiﬁcant difﬁculty in the delivery
of proteins through the cell membrane. Iron-gold hybrid nanoparticles (HNP-C) application offers a promising tool
for cytochrome-c delivery into tumour cells and enhances the speciﬁc targeting of therapeutic particles to their site
of action.
Anticancer drugs (doxorubicin, paclitaxel, oxaliplatin, vinblastine and vincristine) with different mechanisms of
action were used to treat the HepG2 cells at speciﬁc concentrations to assess their IC50 values, and subsequently
the cells were treated with each one of these drugs in combination with HNP-Cytochrome C showing a 10% growth
inhibition alone in HepG2 cells.
The successful delivery of pro-apoptotic protein (cytochrome-C) using hybrid iron-oxide gold nanoparticles can
be considered as a promising step in the liver cancer treatment by working in synergism pattern with anticancer
drugs and signiﬁcant decrease in the IC50 of each drugs combination against the HepG2 cells viability.2016 | Volume 1 | Issue 2 |
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AbstractThermally Polymerized Hyper branched Polymers: Effect of Histidine on
the Structure of Hyperbranched Polylysine and Its Application as a Non-
Viral Vector for Gene Delivery
Ali Alazzo*
University of Nottingham/School of Pharmacy
Non-viral gene delivery systems have been investigated for many years; however, the successful clinical translation
of this approach is still limited due to several biological and technical obstacles that should be overcome to prepare
a successful vector. Highly branched and easily functionalized polymers have emerged as an attractive solution to
address these barriers. In this context, hyperbranched polymers represent a promising alternative to dendrimers
for their advantages in terms of cost that make synthesis more feasible and applicable for scale up and manufactur-
ing. Here, we investigated the effect of histidine on the structure and gene delivery applications of thermally po-
lymerized hyperbranched polylysine. The structural analysis indicated that the incorporation of histidine modulates
the structure of hyperbranched polylysine to produce a more dendritic polymer with less ﬂexible branches. Addi-
tionally, the results revealed that there was a negative correlation between the content of histidine in the polymers
and their capability to condense and deliver nucleic acid.2016 | Volume 1 | Issue 2 |
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AbstractLoading and Release of Noval Gemcitabine Adduct Onto Hybrid Gold
Iron-Oxide Nanoparticle for Pancreatic Cancer Therapy
Mohanad Alfahad*
Institute of Science and Technology in Medicine (ISTM), Keele University
Pancreatic cancer is the fourth main cancer in the western world. Gemcitabine treatment only proves effective in
23.8% of patients with pancreatic cancer. Nanotechnology can play an essential role by delivering anticancer drugs
to the malignant cells in a targeted fashion,
In this part of the study, we have investigated the Prodrug attachment to hybrid nanoparticle surface via dative
covalent linkage.
The HNP were synthesized, coated with PEI and gold. Prodrug of Gemcitabine was synthesized using established
procedures.
Attachment of prodrugs on to HNP surface was quantiﬁed using reverse phase HPLC. In vitro drug release studies
were carried out at different temperatures.
Novel prodrugs of gemcitabine were isolated and characterized. HNPs were synthesized successfully in the mag-
nitude of 70 nm. Prodrug attachment to HNP was successful with as much as 5mgmL-1 being detected. Drug release
studies indicated that the formulation was stable over the range of temperatures tested.2016 | Volume 1 | Issue 2 |
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AbstractThermoresponsive copolymer: HPMA-CO-(APMA-R) polymer synthesis and
physiochemical characterization
Ali Alsuraiﬁ*
Institute for Science and Technology in Medicine, Keele University, Keele ST5 5BG, UK
Abstract
A limitation associated with cancer treatment arises from the problems in directing highly cytotoxic agents to the
diseased tissues, low solubility in aqueous media and poor bioavailability. Many drug delivery systems have been de-
vised to address this problem, including thermoresponsive polymers. In this study, a novel HPMA-CO-AMPA-R
thermoresponsive copolymer has been prepared to act as drug delivery system and to enhance the solubility of poor
water-soluble drugs via grafted hydrophobic groups onto the primary amine group of APMA monomers using
palmitoyl, dansyl, cholesteryl and 5-(4-chlorophenyl)-1,3,4- oxadiazole. The product characterization was carried
out by FTIR, NMR and Zeta Sizer. Drug loading and release abilities of HPMA-CO-AMPA-R copolymers were deter-
mined by using HPLC.
The result showed that all the HPMA-CO-APMA-R derivatives (6 mgmL-1, at initial drug:polymer loading ratio of
10:1) successfully improved the aqueous solubility up to 394-fold in comparison with the aqueous medium method.
(Figure 1 ).y each modiﬁed polymer.Figure 1. Maximum propofol concentration solubilised b2016 | Volume 1 | Issue 2 |
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AbstractNanoparticle characterization and trapping using open microcavities
Aurelien Trichet*
University of Oxford, Department of Materials
Within the last decade, optical resonators, thanks to their low mode volume and/or high ﬁnesse, have emerged as a
promising avenue to isolate and measure real-time properties of single nanoparticles such as viruses or gold nano-
particles. Such trapping devices with sensing capabilities are on the verge of ﬁnding powerful applications in inter-
disciplinary science. However, the quest for a candidate bringing together in-situ detection, trapping and multiple
quantitative measurements of the particle properties supported by a comprehensive understanding still remain
elusive.
In this work, we show that open-access microcavities fulﬁl these criteria by trapping and characterizing 200 nm
diameter nanoparticles. Our results demonstrate that these microcavities can be used as optical tweezers with
in-situ force calibration and nanoparticle sensing capabilities, with no need for a priori knowledge of the particle
properties. Additionally, we can potentially access the aspect ratio of the nanoparticles, an essential measurement
in nanotoxicology.noaprticle. Bottom left: Mode shift recorded during a trap-Figure 1. Top: Schematics of the microcavity and the na
ping event. Bottom right: Trap depth measurement.
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AbstractNovel mustard produgs and their use in magnetic nanoparticle directed
enzyme produg therapy
Patrick Ball*
Bangor University
Directed enzyme prodrug therapy (DEPT) is a form of cancer chemotherapy that involves the delivery of prodrug-
activating enzymes to a tumour before administering a prodrug to the patient, resulting in a higher local toxicity
than current chemotherapy strategies. The bacterial nitroreductase NfnB has been investigated for potential use
in DEPT in combination wuth the CB1954 prodrug and this combination has even reached the clinical trial stage.
A mojor limitation of this technology is the dose limiting toxicity of the CB1954 prodrug and as such other produgs
need to be explored for use in DEPT strategies. The two novel mustard prodrugs, PR-104A and SN27686, developed
at Auckland University, New Zealand, are the most promising prodrugs available and as such are currently being
tested in combination with the NfnB enzyme using the novel gold-coated magnetic nanoparticle delivery system de-
veloped at Bangor University, Wales.2016 | Volume 1 | Issue 2 |
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AbstractCorrelating the cytotoxic and genotoxic potential of few-layer graphene
ﬂakes with their physico-chemical features
Mike Burgum*
Swansea University
Few-layer graphene (FLG), deﬁned as possessing three or more atomic layers of graphene, is a revolutionary mate-
rial stronger than diamond and more conductive than copper. The present study sought to assess the toxicological
impact of 700m2/g FLG ﬂakes engineered with (i) no speciﬁc functionality, (ii) amine groups or (iii) carboxyl groups.
Each FLG was then exposed to a representative human airway epithelial monoculture of 16HBE14o- cells.
Size and morphology of the ﬂakes were characterised with scanning electron microscopy (SEM) and atomic force
microscopy (AFM). Cell viability and chromosomal damage were assessed by relative population doubling (RPD) and
the cytokinesis block micronucleus (CBMN) assay respectively.
FLG induced no signiﬁcant cytotoxicity at any of the tested concentrations. In contrast, at sub-lethal concentra-
tions, signiﬁcant genotoxicity was induced by both non- and amine-functionalised FLG from 20μg/ml whilst the car-
boxyl-functionalised ﬂakes induced a signiﬁcant response at 100μg/ml.2016 | Volume 1 | Issue 2 |
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AbstractAbstract
Jake Casson*
University of Glasgow
Skeletal metastasis is prevalent in many cancers, in particular epithelial tumours (eg. breast cancer). It is now
evident that, in the early stages of metastatic spread, disseminated tumour cells in the bone marrow undergo an
extended period of growth arrest in response to the microenvironment, a phenomenon known as dormancy.
Understanding the mechanism of transition from dormancy to a recurrent growth state is limited by the availability
of physiologically relevant models. In this project we have developed a co-culture model to explore this transition,
utilising 3D cell spheroids of both breast cancer cells and bone marrow mesenchymal stromal cells, co-cultured over
a monolayer of intact or scratch wounded ﬁbroblasts. The release of interleukin-6 (IL-6) has been documented when
performing a scratch assay on ﬁbroblasts. Our ﬁndings indicate the presence of IL-6 causes breast cancer cells to
migrate out of the spheroid, indicating a switch from dormancy to an active growth state.2016 | Volume 1 | Issue 2 |
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AbstractSingle Molecule Imaging of Membrane Protein Function and Organisation in
Droplet Interface Bilayers
Dr Oliver Castell*
Cardiff University - College of Biomedical and Life Science, School of Pharmacy and
Pharmaceutical Sciences
Droplet Interface Bilayers (DIBs) represent artiﬁcial mimics of the cell membrane suitable for biophysical studies
and applications in synthetic biology. Self-assembly of lipid at a droplet water-oil interface creates a lipid mono-
layer, and the contacting of two such interfaces forms a bilayer. Functional membrane proteins can be reconstituted
into these bilayers. Total Internal Reﬂection Fluorescence (TIRF) microscopy can be used to make dynamic single
molecule measurements, allowing the unpicking of intrinsic molecular mechanisms of the membrane, with a level
of insight not afforded by traditional ensemble techniques. Here we highlight the use of droplet interface bilayers
to make optical measurements of protein function and to make single molecule measurements on the dynamics of
membrane organisation. Such measurements in well controlled model systems serve to increase our understanding
of the membrane at the molecular level, providing unique insight into the nanoscale mechanisms underpinning com-
plex cellular functions.2016 | Volume 1 | Issue 2 |
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AbstractInvestigation of a Drug Releasing Tamponade Agent
Dr Helen Cauldbeck*
University of Liverpool, Department of Chemistry
Complicated cases of retinal detachment are treated with silicone oil (SiO) tamponades which can potentially be
used as drug reservoirs. Various methodologies to develop a sustained and controlled drug release, for a clini-
cally-relevant release period, 6-8 weeks, from SiO tamponades were investigated. The solubility and release of
drugs from SiO was assessed using radioisotope techniques. The formation of prodrugs and novel polymer architec-
tures with hydrophilic components that show considerable miscibility. Further additive development of SiO may
produce enhanced and tailored release proﬁles. Cytotoxicity of drugs and synthesised additives were studied
against an adult retinal pigment epithelium cell line (ARPE-19).2016 | Volume 1 | Issue 2 |
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AbstractTargeted nanoparticle delivery of a novel nitric oxide donor increased fetal
weight in a mouse model of fetal growth restriction
Natalie Cureton*
University and Institution: Insitute of Human Development, University of Manchester
Abstract
Pregnancy complications are often attributed to poor uteroplacental blood ﬂow, but the risk of systemic
side-effects hinders therapeutic intervention. We have used novel peptide-conjugated liposomes that selectively
bind to the uteroplacental vasculature to deliver the vasodilator compound SE175 to pregnant endothelial nitric
oxide synthase knockout mice, a well-characterised model of fetal growth restriction (FGR).
Liposomes containing SE175 or PBS were prepared by lipid ﬁlm hydration and targeting peptides coupled to the
liposomal surface. Vehicle control, free SE175, PBS- or SE175-containing liposomes were intravenously injected
on embryonic (E) days 11.5, 13.5, 15.5 and 17.5. Animals were sacriﬁced at E18.5 and fetal and placental weights
recorded.
Targeted delivery of SE175 signiﬁcantly increased fetal weight compared to vehicle control but no other treat-
ment groups, whilst signiﬁcantly decreasing placental weight, indicating improved placental efﬁciency.
These data suggest that selective delivery of SE175 to the uteroplacental vasculature may represent a novel
treatment for FGR.2016 | Volume 1 | Issue 2 |
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AbstractPreclinical assessment of G2’:2000PEG-pHPMA100¬EGDMA0.8 polymeric
nanoparticles.
Christopher David*
University of Liverpool, Department of Molecular and Clinical Pharmacology
Polydendrons, a novel nanomaterial, were characterised and subjected to in vitro toxicological and immunological
tests. Four polydendrons; comprising two ratios of G2 dendron initiator to PEG, in two sizes, were measured for size
and surface charge in various media via dynamic light scattering and zeta potential. Sample sterility, cytotoxicity,
ROS generation, glutathione reduction, and inﬂuence on autophagy were assessed. Notably the smaller 50:50
polydendron generated 1.35- and 9.64-fold increases in IL-1β and TNFα respectively compared to an untreated con-
trol. Also, a 1.53-fold increase in leukocyte proliferation was observed, with no signiﬁcant effects on plasma coag-
ulation, complement activation, or haemolytic potential.2016 | Volume 1 | Issue 2 |
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AbstractTraceable Micro dosed 67Ga-Magnetite-ﬁlled Micelles for Antigen/Adjuvant
Lymph Node Delivery
Ruiz de Angulo*
CIC biomaGUNE
Abstract
Many pathogens and cancer cells have evolved mechanisms to evade the host immune response, creating an ur-
gent need for developing new, safe and effective vaccine technologies.[1] Herein we designed PEGylated magnetite-
ﬁlled nanoparticles as delivery systems to direct tumour antigens and/or adjuvants to lymph nodes (LNs).
Taking advantage of respective size properties, these nanovaccines allow both immunogenic molecules to be
targeted to the same cells within the LNs. Considerably improved vaccine efﬁcacy is observed as a result of this
targeted delivery, inducing potent humoral and cellular immunity at low doses, in turn leading to effective antican-
cer effects in mouse models for human melanoma.[2] Exploiting a radiolabeling method based on direct attachment
of 67Ga(III) ions to the magnetite core, the nanovaccines are tracked by SPECT/CT in vivo. These imaging studies
show effective migration of the nanovaccines to the tumour and LNs, which offers important opportunities for de-
veloping anticancer vaccines.References
[1] D. M. Morens, G. K. Folkers, A. S. Fauci, Nature 2004, 430, 242–9.
[2] A. Ruiz-de-Angulo, A. Zabaleta, V. Gómez-Vallejo, J. Llop, J. C. Mareque-Rivas, ACS Nano 2016, 10, 1602–18.2016 | Volume 1 | Issue 2 |
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AbstractBranched polymerisation systems as stable emulsiﬁers for nanoemulsion
drug delivery
Stephanie Edwards*
University of Liverpool, Chemistry Department
A series of novel polymeric surfactant architectures incorporating hydrophobic and hydrophillic chain ends have
been synthesised by Atom-transfer radical-polymerisation (ATRP) to create branched vinyl polymers for use as sur-
factants. The stability of oil-in-water emulsions has been studied and optimised by varying the molar ratio of hydro-
phobic and hydrophilic chain ends via a mixed initiator system. This produces multiple hydrophobic chains within
the branched system to produce a stable emulsiﬁer system. A range of stable emulsions have been formulated
where the hydrophobic content of the polymers can be reduced to a minimal amount while maintaining compara-
tive droplet size. The emulsions can be tailored to either the micro or nano scale by varying the emulsiﬁcation tech-
nique, while maintaining stability over sustained time periods. Further functionality can be included by the addition
of dendritic chain ends, which allows for continued research into their potential is mucoadhesives.mulsion stabilised by a range of polymeric surfactants.Figure 1. Schematic representation of an oil-in-water e2016 | Volume 1 | Issue 2 |
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AbstractEnhancing the antitumour therapeutic effect of a Pt(IV) prodrug with iron
oxide nanocarriers
Amaia Garaikoetxea*
CIC biomaGUNE
Platinum (II) complexes such as cisplatin are still among the best chemotherapeutic agents for the treatment of a
variety of tumours.1 Their clinical use, however, has important drawbacks (resistance, efﬁcacy etc.) and is dose-
limited by systemic toxicity. A new generation of Pt(IV) prodrugs are showing considerable potential for overcoming
some of these issues.2 The use of nanoparticles as nanocarries offers great advantages both to improve the delivery
and therapeutic index of these prodrugs and to monitor drug targeting by multimodal imaging.
Our previous studies have proven the efﬁcacy of biocompatible iron oxide nanoparticles to enhance the cancer
killing effect of a cisplatin Pt(IV) prodrug in prostate cancer cells.3 Here we report a system that is tracked
in vivo with high sensitivity, provides 10-fold reduction on the prodrug’s IC50 and dramatic improvement of the
in vivo antitumour effects in a highly aggressive murine model of metastatic melanoma.References:
[1] Graf, N.; Lippard, S.J. Adv. Drug Delivery Rev. 2012, 64, 993-1004.
[2] Gao, J.; Gu, H.; Xu, B. Acc. Chem. Res. 2009, 42, 1097-1107.
[3] Hernández-Gil, J.; Cobaleda-Siles, M.; Zabaleta, A.; Salassa, L.; Calvo, J.; Mareque-Rivas, J.C. Adv. Healthcare
Mat. 2015, 4, 1034-1042.2016 | Volume 1 | Issue 2 |
Page 52
AbstractResponsive, Quantum Dot Functionalised Amphiphilic Block Copolymer
Nanoprecipitates; a Proof-of-Concept Model for Rapid Detection Tests
(RDT) for Infectious Disease Diagnostics
Marco Giardiello*
University of Liverpool/Tandem Nano
Rapid Detection Tests (RDT) for diagnosis of a variety of infectious diseases are of considerable importance, with
early detection being crucial for rapid administration of therapy to maximise pathogen suppression. Herein, a
proof-of-concept model focussing on the use of Quantum Dot (QD) technology towards development of generic,
highly sensitive RDTs is presented. A critical issue in RDT development is the frequency of misdiagnosis through false
negatives; signal ampliﬁcation is therefore vital. Herein, signal accumulation is achieved through a
nanoprecipitation synthetic method using dual QDs with thiol functionalised nanoprecipitates of amphiphilic block
copolymers. The triple component organic/inorganic nanoparticles (Dz ~110 nm) show single wavelength absorption
(λex = 495 nm) and dual emission (λem = 515 nm and λem = 560nm) with quantitative and highly sensitive response to
dye quenching. The proof-of-concept model demonstrates the potential to be adapted towards highly sensitive
pathogenic response for a variety of infectious diseases.References
[1] D. M. Morens, G. K. Folkers, A. S. Fauci, Nature 2004, 430, 242–9.
[2] A. Ruiz-de-Angulo, A. Zabaleta, V. Gómez-Vallejo, J. Llop, J. C. Mareque-Rivas, ACS Nano 2016, 10, 1602–18.2016 | Volume 1 | Issue 2 |
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AbstractIron Oxide Nanocubes with High r2 Relaxivity Decorated with Pt(IV) Prodrug
for Multimodal Imaging and Cancer Therapy
Nina Gómez Blanco*
CIC biomaGUNE
The main clinical application of iron oxide nanoparticles (IONPs) is as contrast agents for Magnetic Resonance
Imaging (MRI). Furthermore, they can be engineered for developing effective theranostic nanosystems that
integrate multimodal imaging and cancer therapy.1 In this context, we are exploring IONPs labelled with 67Ga in
combination with platinum anticancer prodrugs to create a SPECT-MR imaging vehicles which can deliver cisplatin
in the reducing environment of tumors. In order to achieve optimal r2 relaxivity,
2 we prepared IONPs with different
shapes and sizes and solubilised them in water by encapsulation within PEG-phospholipids micelles.
Results show that 21-nm cubic IONPs have the highest r2 values and have no appreciable toxicity. When decorated
with Pt(IV) prodrug, they are efﬁcient therapeutic agents against cancer cells. In this contribution we also discuss
how 67Ga-IONP theranostic nanocubes target lymph nodes and can be monitored in vivo and ex vivo by SPECTand MR
imaging.References
[1] Hernández-Gil, J.; Cobaleda-Siles, M.; Zabaleta, A.; Salassa, L.; Calvo J.; Mareque-Rivas, J. C.; Adv.
Healthcare Mater. 2015, 4 (7), 1034-1042.
[2] Lee N.; Choi Y.; Lee Y.; Park M.; Kyung Moon W.; Hong Choi S.; Hyeon T.; Nano Lett. 2012, 12, 3127-3131.2016 | Volume 1 | Issue 2 |
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AbstractXanthate Mediated Sequential Thiol-Acrylate Michael addition
Faye Hern*
University of Liverpool
Thiol-Michael addition chemistry beneﬁts from; mild reaction conditions, minimal by-product formation, high func-
tional group tolerance and high conversion. We have previously shown that xanthates, acting as masked thiols, un-
dergo one-pot deprotection/thiol-acrylate Michael addition to introduce functionality at the surface of dendritic
polyesters. Here, we compare the rapid simultaneous and stepwise sequential controlled surface group modiﬁca-
tion of these materials to selectively introduce desired amounts of surface groups with a range of functionalities
(Figure 1). The controlled deprotection and functionalisation of a range of dendritic materials with varying gener-
ations and molar ratios of mixed acrylates has allowed the targeting of materials with a range of molar concentra-
tions of functional groups using a small number of starting materials.xanthate functional dendron undergoing: (A) Stepwise par-Figure 1. Schematic representation of third generation
tial one-pot xanthate deprotection/thiol-acrylate functionalisation strategy, followed by deprotection of remaining
xanthate groups/ thiol-acrylate functionalisation; (B) Competitive full xanthate deprotection/thiol-acrylate
multifunctionalisation.
2016 | Volume 1 | Issue 2 |
Page 55
AbstractDevelopment and Characterisation of Antiretroviral Drugs Encapsulated in
Polymer Stabilised oil-in-water Nanoemulsions
James Hobson*
University of Liverpool
Oil-in-Water Nanoemulsions loaded with either efavirenz or lopinavir were prepared using homogenisation/solvent
evaporation technique to increase the concentration of drug in an aqueous environment. The ability of NEs to per-
meate intestinal barriers was assessed using Caco-2 transwell system, EFV and LPV loaded NEs were compared with
aqueous solutions. NE LPV had signiﬁcantly increased permeation compared to aqueous LPV, with apparent perme-
ability (Papp) of 6.4 x 10-5 cm/s vs 2.7 x 10-6 cm/s (p= <0.05). Comparable results being observed for NE EFV com-
pared to aqueous EFV, with Papp values of 1.1 x 10-5 cm/s and 8.2 x 10-6 cm/s respectively (p=<0.05).2016 | Volume 1 | Issue 2 |
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AbstractThe Evaluation of Novel Antibody Drug Conjugate Payloads
David Howard*
Swansea University Medical School
Antibody drug conjugates (ADCs) are an emerging class of anti-cancer agents showing great promise in the treat-
ment of advanced cancers. ADCs consist of a tumour-targeting monoclonal antibody conjugated to a cytotoxic pay-
load via blood-stable linkers. These prodrugs bind antigens on the tumour cell surface, are internalised, and upon
release of their toxic payloads, induce cell death. Despite the over ﬁfty ADCs currently undergoing clinical trials,
only a limited number of different payloads are featured. In light of the challenges inter- and intra-tumour hetero-
geneity and drug resistance pose to cancer treatment, the expansion of the ADC war chest with payloads operating
by diverse mechanisms could prove important in improving ADC efﬁcacies. Herein we describe our efforts to identify
and evaluate novel ADC payloads. We report on the anti-tumour effects of a novel ADC payload candidate showing
promising efﬁcacy in both type I and II endometrial cancer cell-lines.2016 | Volume 1 | Issue 2 |
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AbstractBiodegradable Polyphosphazene-based nanocomplex functionalized by
thiol-ene click chemistry for controlled gene release
Wei-Hsin Hsu*
University of Nottingham
In polymeric gene delivery, a biodegradable versatile material with low toxicity has been a predominant criterion.
Polyphosphazene is an artiﬁcial bioerodible polymer, with potential to generate ample derivatives for pharmaceu-
tical purpose. Herein, we explored the use of a known allylamine-substituted polyphosphazene as a precursor and
presented ﬂexible click-chemistry for avoiding unwanted side reactions. We designed a mixed-complex with cat-
ionic and anionic polyphosphazenes, not only for stably binding pDNA but also for controlled release of pDNA in
endosomal environment. While Mix-plex incubated in the acid environment, the TEM images showed separate
phases inside the nanoscale complex, likely indicating pH-induced structural change might facilitate release of
pDNA. In transfection of 3D-spheroid of U87MG, Mix-plex can promote gene-transfection into tumour cells, com-
pared with the conventional polyplex. In summary, this polyphosphazene-based nano-complex not only presented
functional modiﬁcation for controlled gene release as well as provided various promising derivatives in gene
delivery.2016 | Volume 1 | Issue 2 |
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AbstractCEA-Adhiron functionalised Silica nanoparticles allow speciﬁc in vitro
ﬂuorescent imaging of colorectal cancer cells.
Dr Yazan S. Khaled*
University of Leeds, Nanotechnology Group
Abstract:
Background: There is a need for real-time imaging of colorectal cancer (CRC) to allow tailored surgery. Fluores-
cent nanoparticles may offer a solution with non-immunoglobulin (non-Ig) targeting molecules possessing advan-
tages over antibodies.
Aim: We aimed to develop and test ﬂuorescent silica nanoparticles targeted against CRC using an anti-
carcinoembryonic antigen (CEA) Adhiron (Ad).
Methods: Anti-CEA or control Ads were conjugated to silica nanoparticles. Binding of CEA-Ad or control nanopar-
ticles to CRC cells was quantiﬁed in vitro using confocal microscopy.
Results: Dye-doped-(NIR664)-silica nanoparticles were synthesised with a median diameter of ~60 nm. CEA-
targeted, SMCC-conjugated nanoparticles, but not control nanoparticles, allowed strong tumour-speciﬁc ﬂuores-
cence when incubated with LoVo (p=0.021), LS174T (p=0.041), and HT29 (p=0.03) respectively. There was no
signiﬁcant difference in ﬂuorescence for CEA-Adhiron vs. CEA-Antibody targeted nanoparticles.
Conclusion: We are the ﬁrst to demonstrate speciﬁc, in vitro imaging of CRC cells using Adhiron-targeted ﬂuores-
cent nanoparticles. CEA-Adhiron appears to be a suitable non-Ig targeting molecule.2016 | Volume 1 | Issue 2 |
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AbstractBeneﬁts and Effects of Nanoparticle Assisted Microwave Imaging
Rachita Lahri*
Institute of Pharmaceutical Science, School of Biomedical Sciences, King’s College London
Microwave imaging is a new imaging modality which has attracted a lot of attention recently. Microwave imaging is a
technique that exploits the dielectric contrast at microwave frequencies between malignant and the healthy tis-
sues. Microwave – frequency dielectric properties difference between malignant and healthy adipose dominated
tissue in the breast is as large as 10:1. However the contrast between malignant and normal glandular/ﬁbro-
connective tissue in the breast is no more than 10%. This contrast can be improved by the use of various nanopar-
ticles. Dielectric properties of silicon dioxide, titanium dioxide, zinc oxide and different carbon nanotubes have
been measured in water for this study. A signiﬁcant increase was seen within the dielectric properties when carbon
nanotubes were added in water. On the other hand, there was no signiﬁcant increase seen within the dielectric
properties when silicon dioxide, titanium dioxide and zinc oxide were added in water.2016 | Volume 1 | Issue 2 |
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AbstractPeptide nanomaterials as Targeted Therapies for Glioblastoma
Diana Moreira Leite*
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biological
Sciences, University of Portsmouth
Brain diseases are responsible for 12% of global deaths and their treatment could beneﬁt from the use of highly po-
tent and speciﬁc pharmaceuticals with low inherent toxicity and immunogenicity such as neuropeptides 1. However,
for neuropeptide therapies to be realised, peptides need to be able to cross the blood-brain barrier (BBB) and pos-
sess enhanced enzymatic stability to ensure adequate brain bioavailability. Lipidisation of peptides has been proven
to be a useful strategy to enhance enzymatic stability and BBB permeability, while increasing the amphiphilicity of
neuropeptides allows their self-assembly in well-deﬁned nanostructures 2,3. We have developed a neuropeptide
amphiphile able to self-assemble and entrap brain impermeable drugs, which; possess enhanced stability to enzy-
matic degradation, permeates the BBB (all human in vitro BBB model) and targets receptors overexpressed in glio-
blastoma cells resulting in a novel targeted nanomedicine with a strong anti-proliferative and apoptotic effects
in vitro. The proposed nanomedicine can be readily translated and proof of concept in an animal model is under
way.
References
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AbstractMADIX Polymerisation of Vinyl Acetate to Complete Conversion with High
Molecular Weight Control
Martin Levere*
Department of Chemistry, University of Liverpool
Poly(vinyl acetate) is the synthetic precursor of water soluble non-toxic poly(vinyl alcohol), often used in
nanomedicine formulations. A series of MADIX polymerisations were performed for 48 h at 70 °C in bulk and using
DCM and ethyl acetate as solvents with ratio [CTA]0/[AIBN]0= 1/0.2. When polymerisations are performed in bulk,
the reaction is diffusion limited and reaches only 85% monomer conversion. However, >95% monomer conversion
can be achieved reproducibly by using solvents to overcome the diffusion limit. Signiﬁcantly, experimental Mn
matches theoreticalMnwhen ethyl acetate is used, whilst in bulk and DCM the experimentalMn is signiﬁcantly lower
than the theoretical Mn value. This result shows optimal conditions for the MADIX polymerisation of vinyl acetate,
with minimal waste and could potentially be expanded to radiolabelled vinyl acetate.etate after 48 h at 70 °CFigure 1. Comparative monomer conversions of vinyl ac2016 | Volume 1 | Issue 2 |
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AbstractThe utilisation of novel characterisation technique to enable nanomedicine
design
Edyta Lewandowska*
University of Liverpool, Department of Chemistry, UK
The interest of nanomedicine has grown substantially over the last 30 years. Due to this growth, it has become very
important to obtain analytic techniques to provide high resolution characterisation particles with nanometric size.
A promising approach is to fractionate nanoparticle distributions through the use of asymmetric ﬁeld ﬂow fraction-
ation (AF4). This method is particularly useful when analysing samples in complex biological media. Our research is
focused on the development of an approach that allows the use of AF4 to show how nanomedicines behave in bio-
logical environments. In our poster, we will outline the use of AF4 to provide accurate, high-resolution sizing of mul-
timodal nanoparticle distributions (see Figure 1).polystyrene as analysed by AF4 using an in-line UY-Vis de-Figure 1. Example of separation iron nanoparticles from
tector (300 nm) and dynamic light scattering measurement.
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AbstractMagnetically levitated spheroids as a model of the stem cell niche.
Natasha Lewis*
University of Glasgow
We have developed a technique to generate mesenchymal stem cell (MSC) spheroids using magnetic nanoparticles.
Brieﬂy, cells are initially loaded with magnetic nanoparticles, and suspended in a well plate beneath a magnet to
induce cell levitation. After 24 hours, multicellular spheroids self-assemble and can be subsequently implanted into
a collagen gel to mimic the bone marrow microenvironment. These remain quiescent and expression of cell cycle
progression genes is downregulated compared to corresponding monolayer cultures. In addition, the MSC spheroids
produce hematopoietic stem cell (HSC) supportive cytokines such as CXCL-12, allowing co-culture with HSCs. Inter-
estingly, central necrosis is not observed even with increasing spheroid size, in contrast to other commonly used
spheroid systems. In summary, this spheroid culture system presents a potential tool for modelling in vitro stem cell
niches and elucidating interactions between cells.crographs (D, E, F) of spheroids made from different initialFigure 1. Transmission (A, B, C) and scanning electron mi
cell seeding densities. Nanoparticles are clearly packaged into vesicles within the cells and do not cause toxicity.
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AbstractProtein conjugation to nanoparticles by designer afﬁnity tags
Wenwei Ma*
University of Lincoln
Conjugation of biomolecules to nanoparticles can be achieved using well-established chemistries. However, when it
comes to structurally complex molecules such as proteins, their diversity makes it difﬁcult to ﬁnd a unique chemical
cross-linking method that consistently produce functional conjugates. Therefore, protocols for immobilisation have
to be empirically and tediously optimised case-by-case. Passive adsorption is a straightforward method for decora-
tion of nanoparticles but unfortunately the adsorbed protein is thought to undergo denaturation and may not be
uniformly oriented.
To address this, we are developing intermediate designer proteins that adsorb onto gold nanoparticles and carry a
domain which speciﬁcally binds to an afﬁnity tag. An arbitrary protein of interest which presents the tag can bind
the functionalised particles by simple mixing, with reduced chance to undergo denaturation. Importantly, there is
no need for optimisation of the conditions, as these are only determined by the afﬁnity system and not by a nano-
particle-protein interaction.2016 | Volume 1 | Issue 2 |
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AbstractManipulation of Mesenchymal Stem Cell Differentiation via Gold
Nanoparticle-mediated Delivery of Antagomirs
Shijoy Mathew*
University of Glasgow
The human body is complex and prone to deterioration. With advances in medicine and the resultant increased life
expectancy, there are several signiﬁcant age-related conditions involving bone or cartilage deterioration and dam-
age, primarily osteoarthritis and osteoporosis. Regeneration of these tissues via mesenchymal stem cells (MSCs) in
the bone marrow is an on-going challenge.
The use of nanoparticles as a delivery platform in medicine is gaining recognition, due to the beneﬁts conferred
by their small size, non-toxicity and multi-valency, which allow for a safer and customizable method of delivery.
This project aims to use gold nanoparticles to deliver antagomirs (anti-miRNAs) to MSCs, with the aim of manip-
ulating key miRNAs involved in MSC differentiation. MiRNAs are short sequenced RNAs that are involved in the reg-
ulation of nearly 30% of the genes in the body. This project aims to exploit their function to promote MSC
differentiation into bone or cartilage cells.2016 | Volume 1 | Issue 2 |
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AbstractRe-purposing Cetuximab as part of a nanoconjugate system directed
against CTX-resistant cancers
William McDaid*
Queen’s University Belfast, School of Pharmacy
The monoclonal antibody Cetuximab (CTX) has demonstrated limited efﬁcacy in the clinic due to activating muta-
tions which allow cancerous cells to acquire resistance. Due to outstanding success as a targeting agent, this study
investigates whether CTX functions better as a targeting agent for drug-loaded nanoparticles (NPs) rather than a
monotherapy against CTX-resistant cells. Cancer cells with different K-Ras mutations (known to mediate CTX resis-
tance) were selected and the inﬂuence of CTX nanoconjugation was assessed with regards to NP uptake and drug
delivery. The chemotherapeutic drug of choice in this study was the topoisomerase I inhibitor, camptothecin
(CPT), which induces DNA damage in cancer cells. It was seen that CTX facilitated preferential NP uptake and
CPT delivery to cells much more effectively than NPs with no surface modiﬁcation. This was evident by an elevated
level of executioner caspase activation and a higher incidence of apoptosis. These results support the premise that
CTX is more competent acting as part of NP conjugate system rather than alone as a monotherapy.2016 | Volume 1 | Issue 2 |
Page 67
AbstractQuantum dots; size dependent anticoagulant properties
Ciarán M. Maguire*
University of Dublin, Trinity College
Abstract
The size-dependent optical properties of Quantum Dots (QDs) are frequently exploited for use in medical imaging
and labelling applications. Similarly, they elicit profound size-dependent anticoagulant properties, a focus for our
research.
3.2 nm cadmium telluride (CdTe QDs) demonstrate a dramatic anticoagulant effect centred on the intrinsic coag-
ulation pathway, compared to their 3.6 nm counterparts. Multiple clinically relevant diagnostic tests were carried
out over a concentration range of the QDs, demonstrating that 3.2 nm QDs elicited their response on the intrinsic
pathway as a whole, yet the activity of the individual intrinsic coagulation factors were not affected. There appears
to be a mechanism strongly inﬂuenced by calcium ion and not cadmium ions concentrations. A number of static and
shear based primary haemostasis assays were carried out, clearly demonstrating a profound platelet and phospho-
lipid independent anticoagulant effect.References
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AbstractFabrication of Plasmonic Nanoscaffolds for Biomedical Applications
Tahereh Tohidi Moghadam Assistant Professor*
Tarbiat Modares University, Tehran, Iran
Abstract
Gold Nanorods (GNRs) are promising candidates for variety of theranostic applications. Here we have exploited
the dual properties presented by hybrid scaffolds of Nano and Bio counterparts, through fabrication of
nanobiotemplates with interesting applications in drug delivery, photothermal therapy and nanobiosensing. GNRs
were synthesised via seed-mediated growth protocol and monitored by characteristic surface plasmon resonance
peaks in the visible and near infrared region. GNRs were incubated in with ﬁxed concentration of insulin at 60 °C
for 7 hours (in HCl 25mM, NaCl 0.1M, pH1.6) and characterized by UV-Visible, Thioﬂavin-T, Circular Dichroism spec-
troscopy, and Transmission Electron Microscopy. The nanostructures were then incubated with amyloid ﬁbrils to as-
semble a nanowires-like scaffold. TEM images revealed ordered aggregates of GNRs on the biotemplate. Results of
this investigation highlighted possibility of directing nanostructured assemblies on amyloid ﬁbril based scaffolds for
future biomedical and biosensing applications in tissue engineering and hybrid drug delivery systems.2016 | Volume 1 | Issue 2 |
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AbstractHollow metallic nanoparticles for mediating cancer therapies
David Morse*
University of Cambridge, Department of Engineering - Nanoscience Centre
Nanoparticles, beneﬁcial for localizing a treatment area, are capable of assembling in cancer tumours. We are de-
signing a gold-decorated, cisplatin ﬁlled, hollow iron nanoparticle to mediate chemo, radio, and thermal therapies
while providing diagnostic feedback. Gold and cisplatin act as high atomic number radiosensitizers, increasing the
potency of mild radiation by releasing auger and photoelectrons in precise locations. The nanoparticles can release
encapsulated drugs and enhance radiation in localized areas; their magnetic properties allow for direct MRI imaging
and thermal ablation. The ﬁndings indicate that this nanoplatform could deliver multiple types of therapy and di-
agnostics at precise locations. As a case-study, we have examined their interaction with glioblastoma multiforme
cell lines. We ﬁnd the particles innately non-toxic but capable of instigating cell death when incited by external
stimuli (e.g., radiation, high intensity focused ultrasound, and magnet ﬁelds).2016 | Volume 1 | Issue 2 |
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AbstractSynthesis of a Temperature Sensitive Hybrid Nanoparticle Drug Formulation
for the Treatment of Pancreatic Cancer
Adeolu Oluwasanmi*
Institute for Science and Technology in Medicine, Keele University
Abstract
Pancreatic cancer remains the deadliest form of cancer in terms of its survival rate of only 3.7% after 5 years. To
ensure the complete removal of adenocarcinomas of the pancreas, chemotherapy and highly invasive surgery has to
be employed which is not possible in many of the elderly patients diagnosed with pancreatic cancer. The treatment
of cancer can be multistep but the effects on the patients wellbeing can accumulate until treatment is no longer a
viable option.
A study of the potential use of a hybrid nanoparticle temperature sensitive drug formulation, to deliver a cyto-
toxic agent via a retro Diels Alder reaction to the site of a tumour is currently underway. The results in Figure 1
for the drug release mechanism of this novel formulation under elevated temperatures, highlight the potential of
these Diels Alder linkers for the reversible attachment of drug molecules to hybrid nanoparticles.r drug formuation over time.Figure 1. Drug release simulation of the retro Diels Alde2016 | Volume 1 | Issue 2 |
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AbstractIn-Vitro Pulmonary Cytotoxicity of Novel Polymeric Nanocarriers for Drug
Delivery
Nashwa Mahmoud Osman*
Liverpool John Moores University, Pharmacy and Biomolecular Sciences
Background: Aliphatic polyesters are widely used for drug delivery applications commonly poly (lactic-co-glycolic
acid), PLGA. A novel polyester; poly (glycerol adipate-co-w-pentadecalactone), PGA-co-PDL was synthesized and
characterized to overcome their common drawbacks. The aim was to evaluate in-vitro cytotoxicity of PGA-co-
PDL nanoparticle (NP) carriers in comparison to PLGA NPs for pulmonary drug delivery. Methods: NP were formu-
lated from PGA-co-PDL and PLGA by single emulsion method and were characterized for size and charge. In-vitro
cytotoxicity was evaluated by Alamar Blue and Reactive Oxygen Species (ROS) assays on Calu-3 cell line. Results:
PGA-co-PDL NPs PGA-co-PDL NPs had good toxicity proﬁle conﬁrmed by Alamar Blue assays. ROS assay showed that
PGA-co-PDL NPs had antioxidant activity in low concentrations (Figure 1). Conclusion: PGA-co-PDL polymer was
successfully formulated into NPs with a suitable size range for pulmonary drug delivery. The results showed a good
toxicity proﬁle of PGA-co-PDL NPs in comparison with the PLGA NPs conﬁrming future suitability for pulmonary drug
delivery.Figure 1. ROS production after 24 hrs exposure to both negative and positive chaged NP of both polymers by ROS
assay (Mean±SD, n=3).
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AbstractAntibody-drug conjugate for gynaecological cancer
Belen Pan-Castillo*
Swansea University
Abstract
Endometrial cancer is the most common gynaecological malignancy with incidence rates in Wales (25%) higher
than in Europe (14%) and North American (16%). Wales presents the worst mortality rate (4.9%) among the UK coun-
tries (3.9%). Therefore, new therapeutics are urgently needed to improve survival rates.
Antibody drug conjugates (ADC) consist of a monoclonal antibody attached to a cytotoxic drug through a linker,
having the ability to target and kill cancer cells only, while avoiding the widespread destruction of healthy cells typ-
ical of traditional chemotherapy. A novel ADC invented by RBGO academics and codename SNIPER, targets a protein
expressed in uterine and ovarian cancers and absent in healthy tissue. Our data indicate SNIPER induces cell death
of endometrial cancer cells more effectively than the current ADC in clinical use (Herceptin-ADC). This project aims
to explore SNIPER safety and efﬁcacy against gynaecological cancers, as an innovative solution to a current health
problem.2016 | Volume 1 | Issue 2 |
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AbstractPhotothermal treatment of cancer cells using gold nanoparticles
Anil Patel
University of Glasgow
Abstract
Using nanoparticles to induce cancer cell hyperthermia and death is a new and developing technique. Cancer cell
vulnerabilities to speciﬁc high temperatures (42-45 °C) are exploited through localised heating of Gold nanoparti-
cles (GNPs). These ‘nanoscale heaters’ absorb and convert near infrared (NIR) light into heat via their surface plas-
mon resonance, thus inducing hypothermia, which in turn induces apoptosis driven cancer cell death.
In this study, Gold nanoprisms and nanorods were cultured with cancer cell lines, both in 2D monolayer and 3D
multicellular tumoroids. Following initial biocompatibility testing, these nanostructures were shown to have no sig-
niﬁcant effect on cell viability (MTT). SEM and TEM scanning demonstrated clear internalisation of both nanoprisms
and rods after 1 hr culture. Utilising a 1W continuous wave 1064nmNR laser, both monolayer and tumoroid cultures
were irradiated, inducing signiﬁcant cell death monitored via live/dead assay. Subsequent RNA analysis via ﬂuidigm
suggested up-regulation of key apoptotic genes, supporting cancer cell apoptosis as a result of hyperthermia
induction.2016 | Volume 1 | Issue 2 |
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AbstractNano-encapsulation of epigenetic modifying drugs for the sensitisation of
Endometrial Cancer and improved therapy
Simone Pisano*
Swansea University
Nanoparticles, due to their size and structure, offer the possibility of targeted drug delivery and an innovative and
promising approach in the treatment of solid tumour cancers. It is effectively known that free drugs often fail to
enter tumour site and exhibit burdensome patient side effects. This project focuses on the fabrication of three
nanoparticle formulations (Pluronic F127, PLGA and Chitosan) and their physical and chemical characterization be-
fore and after encapsulation of a hydrophobic epidrug, SAHA (a HDAC inhibitor). Epigenetic drugs have been broadly
studied on different cancer types. Here we demonstrate epidrug efﬁcacy in an in vitro model of endometrial cancer,
the most common gynaecological tumour. Free drug and nanoparticle encapsulated forms are directly comparable,
demonstrating an effective encapsulation and therapeutic approach which may be a valid and viable delivery
method for future applications in all gynaecological cancers.2016 | Volume 1 | Issue 2 |
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AbstractLong-Acting injectable formulation for children and adolescents using PBPK
modelling
Rajith Kumar Reddy Rojoli*
University of Liverpool
The use of long-acting (LA) antiretrovirals (ARVs) in children and alolescents could represent a valuable pharmaco-
logical option, to simplify regimens, reduce drug costs and improve adherence. Dose optimization in paediatic pa-
tients is complex and physiologically based pharmacokinetic (PBPK) modelling represents a predictive tool to
identify promising dosing strategies. The paediatric patients were simulated using a mathematical description of
covariance between demographics and tissue size expression of metabolic enzymes and processes regulating drug
distribution. The aim of this study was to simulate the pharmacokinetics (PK) of LA ARVs - cobotegravir and
rilpivirine in children and adolescents according to the differnt weight band categories recommended by World
Health Organisation to identify optimal doses using PBPK modeling. These ﬁnding can be potentially used in children
and adolescents adjusting the dosing based on weight, thus broadening the usage of ARVs and providing alternative
strategies for treatment simplication.2016 | Volume 1 | Issue 2 |
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AbstractA Novel Approach for Attaching Targeting Ligands to Liposomal Drug
Delivery Systems
Abbi Abdel Rehim*
Manchester University
Tail anchored proteins are a subgroup of membrane proteins with a single transmembrane region at the C-terminus
that is used to “anchor” the polypeptide into a lipid bilayer. Cytochrome b5 is a tail anchored protein that has been
shown to insert into membranes via a mechanism that is both spontaneous and independent of any cytosolic factors.
This ability for spontaneous insertion may provide a novel approach to attaching targeting ligands to liposomal drug
delivery systems. Here, the capacity of the transmembrane region of cytochrome b5 to attach various N-terminal
domains to liposomes is determined and the effect of the molecules upon the uptake of liposomes by human cells
in culture is being investigated.2016 | Volume 1 | Issue 2 |
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AbstractEarly investigation of the stabilisation effects of polymer and surfactant
combinations in the formulation of solid drug nanoparticles
Alison Savage*
University of Liverpool
Many active pharmaceutical ingredients exhibit poor water solubility, which often impacts bioavailability when
taken as therapy. Recently, a strategy for formulating the antiretroviral Efavirenz into solid drug nanoparticles
(SDNs) has been presented, with resulting products under investigation in human trials. Preparation of SDNs relies
on emulsion-templated freeze-drying, involving a screening process using different polymers and surfactants.
Whilst this method can identify suitable sets of excipients to stabilise the SDNs, the mechanisms behind this
stabilising effect are not fully understood. A polymer and surfactant set that produce Efavirenz SDNs were investi-
gated using isothermal titration calorimetry, to determine whether interactions between excipients and drug par-
ticle surface direct formation of nanoparticles. This was compared to excipient sets that failed to produce SDNs, to
provide insight into any excipient effects. Data presented shows tentative correlations between positive interac-
tions and SDN formation but additional study is required for broader understanding of the multi-variate mechanisms
involved.2016 | Volume 1 | Issue 2 |
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AbstractSingle channel analysis reveals fundamental gating defects of sudden
cardiac death-linked mutant cardiac ryanodine receptors
N. Lowri Thomas*
Cardiff University School of Medicine
Rhythmic contraction of the myocardium depends on the controlled release of Ca2+ from intracellular stores via car-
diac ryanodine receptors (RyR2), and dysfunction of mutant RyR2s is linked with arrhythmia in the form of catechol-
aminergic polymorphic ventricular tachycardia (CPVT). The mechanisms of channel dysfunction have long thought
to be ligand/accessory protein-dependent. However, using single channel analysis under minimal recording condi-
tions we found that, in contrast to wild type (WT) and S2246L channels, N4104K mutant channels exhibited gating
events in the absence of ligand, indicating an inherent effect on channel structure and function. Hidden Markov
Modelling of the gating data showed that this was likely due to an increased susceptibility to enter a conformational
state that favours subsequent opening. This suggests that the unliganded gating exhibited by N4104K channels pro-
motes a heightened propensity for Ca2+ release at the cellular level not seen with mutants which do not exhibit this
fundamental gating defect.2016 | Volume 1 | Issue 2 |
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AbstractNanogel-nanoparticle composites for in situ-forming drug delivery depots
Adam R Town*
Department of Chemistry, University of Liverpool
Prolonged administration of drugs for long term conditions faces the issue of poor patient compliance when fre-
quent repeated administration of drug is required, e.g. a daily oral dose. Pre-formed sustained release implants
overcome this issue but require invasive surgery. In situ-forming implants (ISFI) are easier to administer, allow site
speciﬁc delivery, and ease of manufacture, however ISFIs suffer from issues such as high burst release of drug, tox-
icity and stability of the system. We have synthesised PNIPAM nanogels which are able to rapidly aggregate after in-
jection, in response to physiological conditions, to form a hydrophobic depot for the delivery of poorly water
soluble drugs. The release rate of drug from the aggregate is tuneable, and enhanced when drug is used in solid drug
nanoparticle form. Burst release is minimal despite high drug loading, and sustained release can be maintained for
over 100 days.2016 | Volume 1 | Issue 2 |
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AbstractSynergistic effect of radiotherapy and cis-platinum chemotherapy
delivered via gold nanoparticles in glioblastoma multiforme
Alexandra G. Vaideanu
Department of Engineering, University of Cambridge
Glioblastoma multiforme is reputable in its aggressiveness because the inter- and intra- tumor heterogeneity which
leads to resistance and recurrence. The aim of our work is to demonstrate the efﬁcacy of a multimodal nanotech-
nology in eradicating GBM cell populations in vitro and tumour growth stagnation or reduction in vivo in an
orthotopic xenograft model. We have showed previously1 the synergistic effect of chemotherapy and radiotherapy
in a construct based on spherical gold nanoparticles coated with mercaptoundecanoic acid (MUA) to which we at-
tached cis-platinum drug. To further improve the technology we have used a modiﬁed construct in which we replace
the MUA coating with mixed monolayer made of a small peptide and a polyethylene glycol linker. The ligand shell is
responsible for targeting of the particle to neovasculature and tumor cells due to its tumour homing properties. The
end goal of this work is to validate these ﬁndings via in vivo mouse models and to ultimately submit this technology
for clinical trials.ous gold core functionalized with a RGD peptide ligand andFigure 1. Schematic representation of a multimodal por
a PEG ligand nanoparticle, then bound to cis-platinum drugReference
[1] Setua, S., Ouberai, M., Piccirillo, S. G., Watts, C. & Welland, M. Cisplatin-tethered gold nanospheres for mul-
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AbstractModulating Osteogenesis in Human MSCs by Gold Nanoparticle Delivery of
mir 31A Antagomirs
Aviral Vatsa
University of Glasgow
MiRNAs perform gene regulation that can target approximately 60% of human protein coding genes. We used
antagomir functionalised gold nanoparticles (AuNPs) to block mir-31, which resulted in upregulation of Osx in
pre-osteoblastic MG63 cells and human mesenchymal stem cells (MSCs). Antagomir-functionalised AuNPs were
shown to be non-cytotoxic in either cell type. Fluidigm analysis in MSCs showed a reduction of stem cell marker
genes nestin, alcam, CD63, and CD44 at day 5 (indicating differentiation). RNA analysis in both cell types suggested
a shift away from proliferation towards osteoblastic differentiation. Osx protein levels were increased in both cell
types after 48 hour incubation. Osteocalcin nodule formation demonstrated accelerated osteogenesis at week 3 and
5 following 48 hour AuNP incubation. These results collectively infer successful delivery of mir-31 antagomirs, which
are blocking mir-31-mediated suppression of Osx, resulting in an early increase in Osx, which accelerates MSC oste-
ogenesis downstream.ng
staining at week 3 (PEG=polyethylene glycol, non-functiona
AuNPs); 5’ and 3’= 5’ or 3’ directional miR-31 antagomir f
sponding osteocalcin staining at 3weeks (normalised to
***p<0.001).
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Page 82initial 48 hour incubation with AuNPs. (A) OsteocalcinFigure 1. Acceleration of Osteogenesis in MSCs followi
lised AuNPs; NS=nonsense miR sequence functionalised
unctionalised AuNPs). (B) Semi-quantiﬁcation of corre-
control (no AuNPs), n = 3; error bars denotes SEM,
